MediWound Ltd. announced a $15 million bought deal offering of 1.2 million ordinary shares at $12.50 each, led by H.C. Wainwright & Co. The offering is expected to close around November 5, 2026, with an option for the underwriter to purchase an additional 180,000 shares. Proceeds will be used for working capital and general corporate purposes. This financing supports MediWound's ongoing development of enzymatic therapeutics for tissue repair, including their FDA-approved product NexoBrid and investigational therapy EscharEx.
MediWound's $15 million bought deal offering provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 04, 2026 04:11 WIB: out of 150 priced US health stocks, 92 rose and 55 fell. Notable movers include Aurora Cannabis Inc (ACB) at USD 5.16 with a 22.16% increase and a typical hold time of 26 days, Neurocrine Biosciences Inc (NBIX) at USD 165.00 up 13.52% with 91% sell order activity, and Inovio Pharmaceuticals Inc (INO) at USD 1.65 down 12.96% with a 41-day hold time and 53% sell orders.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
Kadant Inc. announced strong Q3 2026 results with revenue up 15% to $313 million and net income rising 27% to $35 million, driven by 22% bookings growth and operational excellence. Adjusted EPS reached a record $3.64, and operating cash flow increase...
Vext Science reported a 17.6% increase in third-quarter revenue to $14.9 million, driven by a 37% year-over-year rise in Ohio sales, which reached $10.9 million. The company’s operating cash flow doubled from the previous quarter to $2.4 million, hel...
Société Générale has accepted $10 million worth of tokenized U.S. Treasury securities as collateral using the Canton blockchain network. This transaction connected blockchain-based securities transfers with the bank's existing collateral operations, ...
